Picture of genOway SA logo

ALGEN — genOway SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Genoway FY EBITDA Up At EUR 1 Mln

March 30 (Reuters) - Genoway SA  ALGEN.PA :
    * FY EBITDA EUR 1.0 MILLION VERSUS EUR 0.5 MILLION YEAR AGO
    * FY NET LOSS EUR 0.7 MILLION VERSUS LOSS EUR 1.0 MILLION YEAR AGO
    * PROFITABILITY SHOULD INCREASE SHARPLY FROM H2 OF 2022, BY WHICH TIME COST
STRUCTURE SHOULD BE STABILISED AND ALLOW MAXIMUM BENEFIT FROM INCREASE IN
VOLUMES TO REACH AN EBITDA MARGIN OF OVER 25% BY 2024
    * CONFIRMS AMBITIONS OF AN AVERAGE ANNUAL SALES GROWTH OF MORE THAN 20% OVER
2021-2024 IN ORDER TO REACH TURNOVER TARGET OF 30 MILLION EUR
    * FY NET FINANCIAL DEBT INCREASED TO €8.1 MILLION AS A RESULT OF OBTAINING A
€5.1
MILLION "PGE" LOAN IN 2020 FINANCIAL YEAR


Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on genOway SA

See all news